Mon, April 3, 2023
Sat, April 1, 2023
Fri, March 31, 2023
Thu, March 30, 2023
Wed, March 29, 2023
Tue, March 28, 2023

Thomas Shrader Maintained (ATHA) at Strong Buy with Decreased Target to $10 on, Mar 30th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-10-on-mar-30th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Thomas Shrader of BTIG, Maintained "Athira Pharma, Inc." (ATHA) at Strong Buy with Decreased Target from $33 to $10 on, Mar 30th, 2023.

Thomas has made no other calls on ATHA in the last 4 months.



There is 1 other peer that has a rating on ATHA. Out of the 1 peers that are also analyzing ATHA, 0 agree with Thomas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Thomas


  • Jason Butler of "JMP Securities" Reiterated at Buy and Held Target at $20 on, Friday, March 24th, 2023

Publication Contributing Sources